• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切除联合硅油填充术后前房内注射抗血管内皮生长因子治疗晚期新生血管性青光眼

Intracameral anti-VEGF injection for advanced neovascular glaucoma after vitrectomy with silicone oil tamponade.

作者信息

Bai Ling, Tariq Farheen, He Yi-Dan, Zhang Shu, Wang Feng

机构信息

Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710003, Shaanxi Province, China.

Experimental Teaching Center for Clinical Skills, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710003, Shaanxi Province, China.

出版信息

Int J Ophthalmol. 2021 Mar 18;14(3):456-460. doi: 10.18240/ijo.2021.03.20. eCollection 2021.

DOI:10.18240/ijo.2021.03.20
PMID:33747825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7930538/
Abstract

AIM

To evaluate the effect of intracameral injection of conbercept for the treatment of advanced neovascular glaucoma (NVG) after vitrectomy with silicone oil tamponade.

METHODS

Conbercept 0.5 mg/0.05 mL was injected into the anterior chamber of 5 eyes, which had developed advanced NVG after vitrectomy with silicone oil tamponade. Then, trabeculectomy with mitomycin C and pan-retinal photocoagulation (PRP) or extra-PRP were conducted within 2d. The follow-up time was 6mo. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), neovascularization of iris (NVI) were recorded before and after treatment.

RESULTS

Within 2d after injection, IOP control, and NVI regression were optimal for trabeculectomy. Hyphema occurred in one eye in the process of injection. But none of them present hyphema after trabeculectomy. At the end of follow-up time, all eyes had improved BCVA, well-controlled IOP, and completely regressed NVI.

CONCLUSION

Intracameral injection of conbercept is safe and effective in the treatment of patients with advanced NVG after vitrectomy with silicone oil tamponade. Within 2d after injection is the optimal time window for trabeculectomy, which can maximally reduce the risk of perioperative hyphema.

摘要

目的

评估前房注射康柏西普治疗玻璃体切除联合硅油填充术后晚期新生血管性青光眼(NVG)的效果。

方法

对5例玻璃体切除联合硅油填充术后发生晚期NVG的患眼,前房注射0.5 mg/0.05 mL康柏西普,然后在2天内进行丝裂霉素C小梁切除术及全视网膜光凝(PRP)或补充PRP。随访时间为6个月。记录治疗前后的最佳矫正视力(BCVA)、眼压(IOP)、虹膜新生血管(NVI)情况。

结果

注射后2天内,小梁切除术的眼压控制和NVI消退效果最佳。注射过程中有1只眼发生前房积血,但小梁切除术后均无前房积血。随访结束时,所有患眼的BCVA均提高,眼压控制良好,NVI完全消退。

结论

前房注射康柏西普治疗玻璃体切除联合硅油填充术后晚期NVG患者安全有效。注射后2天内是小梁切除术的最佳时间窗,可最大程度降低围手术期前房积血的风险。

相似文献

1
Intracameral anti-VEGF injection for advanced neovascular glaucoma after vitrectomy with silicone oil tamponade.玻璃体切除联合硅油填充术后前房内注射抗血管内皮生长因子治疗晚期新生血管性青光眼
Int J Ophthalmol. 2021 Mar 18;14(3):456-460. doi: 10.18240/ijo.2021.03.20. eCollection 2021.
2
The Optimization of an Anti-VEGF Therapeutic Regimen for Neovascular Glaucoma.新生血管性青光眼抗VEGF治疗方案的优化
Front Med (Lausanne). 2022 Jan 10;8:766032. doi: 10.3389/fmed.2021.766032. eCollection 2021.
3
What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.玻璃体内注射康柏西普对新生血管性青光眼患者的影响:一项前瞻性、干预性病例系列研究。
BMC Ophthalmol. 2019 Jun 11;19(1):128. doi: 10.1186/s12886-019-1138-6.
4
Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.玻璃体内注射bevacizumab 联合硅油填充治疗晚期糖尿病视网膜病变术后新生血管性青光眼
Eye (Lond). 2010 Apr;24(4):717-9. doi: 10.1038/eye.2009.94.
5
The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.不同剂量前房内注射贝伐单抗对新生血管性青光眼小梁切除术手术效果的影响
Eur J Ophthalmol. 2009 May-Jun;19(3):435-41. doi: 10.1177/112067210901900318.
6
Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.玻璃体切割联合全视网膜光凝及小梁切除术成功治疗新生血管性青光眼
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1627-32. doi: 10.1007/s00417-006-0321-7.
7
Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.雷珠单抗联合手术治疗伴有玻璃体积血的新生血管性青光眼
Chin Med J (Engl). 2015 Aug 5;128(15):2078-83. doi: 10.4103/0366-6999.161371.
8
Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma.玻璃体内注射雷珠单抗联合全视网膜光凝后行小梁切除术与艾哈迈德青光眼引流阀植入术治疗新生血管性青光眼的疗效和安全性比较
Int J Ophthalmol. 2017 Mar 18;10(3):400-405. doi: 10.18240/IJO.2017.03.12. eCollection 2017.
9
Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma.康柏西普与雷珠单抗联合丝裂霉素 C 增强小梁切除术治疗新生血管性青光眼的比较。
Int Ophthalmol. 2021 Aug;41(8):2869-2877. doi: 10.1007/s10792-021-01846-6. Epub 2021 Apr 24.
10
The efficacy and safety of intravitreal conbercept combined with mitomycin C augmented trabeculectomy for treating neovascular glaucoma.康柏西普联合丝裂霉素 C 增强型小梁切除术治疗新生血管性青光眼的疗效及安全性。
Discov Med. 2020 Mar-Apr;29(157):113-118.

引用本文的文献

1
Retinal Vein Occlusion-Background Knowledge and Foreground Knowledge Prospects-A Review.视网膜静脉阻塞——背景知识与前沿知识展望——综述
J Clin Med. 2024 Jul 5;13(13):3950. doi: 10.3390/jcm13133950.
2
Construction and validation of a neovascular glaucoma nomogram in patients with diabetic retinopathy after pars plana vitrectomy.糖尿病视网膜病变患者行玻璃体切割术后新生血管性青光眼列线图的构建与验证
World J Diabetes. 2024 Apr 15;15(4):654-663. doi: 10.4239/wjd.v15.i4.654.
3
Comparative efficacy and safety of different anti-VEGF agents combined with different delivery methods for neovascular glaucoma: a systematic review and Bayesian network meta-analysis.不同抗 VEGF 药物联合不同给药方式治疗新生血管性青光眼的疗效与安全性比较:系统评价和贝叶斯网状Meta 分析。
BMJ Open. 2024 Mar 4;14(3):e080103. doi: 10.1136/bmjopen-2023-080103.
4
The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion.视网膜中央静脉阻塞继发新生血管性青光眼的评估方法与治疗进展
Front Med (Lausanne). 2024 Jan 8;10:1280776. doi: 10.3389/fmed.2023.1280776. eCollection 2023.
5
Comparison of the efficacy and safety of ultrasonic cycloplasty valve implantation and anti-VEGF for the treatment of fundus disease-related neovascular glaucoma.超声睫状体成形术瓣膜植入术与抗血管内皮生长因子治疗眼底疾病相关性新生血管性青光眼的疗效及安全性比较
Int J Ophthalmol. 2023 Jun 18;16(6):897-903. doi: 10.18240/ijo.2023.06.10. eCollection 2023.
6
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼。
Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4.
7
Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.与接受康柏西普的 NVG 合并 PDR 患者术中出血减少相关的房水中血管生成因子下调:一项随机对照试验。
BMC Ophthalmol. 2022 May 18;22(1):224. doi: 10.1186/s12886-022-02451-6.

本文引用的文献

1
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼
Cochrane Database Syst Rev. 2020 Feb 6;2(2):CD007920. doi: 10.1002/14651858.CD007920.pub3.
2
Clinical pharmacology of intravitreal anti-VEGF drugs.眼内抗血管内皮生长因子药物的临床药理学。
Eye (Lond). 2018 Jun;32(6):1010-1020. doi: 10.1038/s41433-018-0021-7. Epub 2018 Feb 5.
3
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.青光眼抗VEGF药物作为辅助治疗的当前观点
Adv Ther. 2017 Feb;34(2):378-395. doi: 10.1007/s12325-016-0461-z. Epub 2016 Dec 20.
4
Neovascular glaucoma: a review.新生血管性青光眼:综述
Int J Retina Vitreous. 2016 Nov 14;2:26. doi: 10.1186/s40942-016-0051-x. eCollection 2016.
5
Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma.不同途径注射贝伐单抗治疗新生血管性青光眼的疗效研究
J Curr Glaucoma Pract. 2016 May-Aug;10(2):39-48. doi: 10.5005/jp-journals-10008-1200. Epub 2016 Aug 5.
6
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review.新生血管性年龄相关性黄斑变性中抗VEGF治疗的耐药性:一项综述
Drug Des Devel Ther. 2016 Jun 2;10:1857-67. doi: 10.2147/DDDT.S97653. eCollection 2016.
7
Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications.玻璃体内注射雷珠单抗联合小梁切除术与艾哈迈德人工房水引流阀植入术治疗新生血管性青光眼的疗效及并发症评估
BMC Ophthalmol. 2016 May 26;16:65. doi: 10.1186/s12886-016-0248-7.
8
Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma.前房液血管内皮生长因子与糖尿病视网膜病变、白内障及新生血管性青光眼。
Ophthalmol Ther. 2013 Jun;2(1):41-51. doi: 10.1007/s40123-013-0014-3. Epub 2013 Jun 1.
9
Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.玻璃体内抗血管内皮生长因子单克隆抗体相关的心血管事件和出血风险:系统评价与荟萃分析
JAMA Ophthalmol. 2014 Nov;132(11):1317-26. doi: 10.1001/jamaophthalmol.2014.2333.
10
Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.前房积血是新生血管性青光眼行小梁切除术失败的危险因素:回顾性分析。
BMC Ophthalmol. 2014 Apr 26;14:55. doi: 10.1186/1471-2415-14-55.